Author

Paul Van Hummelen

Stanford MedicineORCID 0000-0002-4801-8600Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:whole-exome sequencing· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Hanlee P. JiiD· 2 shared HoJoon LeeiD· 2 shared James M. FordiD· 2 shared Matthew A. KubitiD· 2 shared Stephanie GreeriD· 2 shared Susan M. GrimesiD· 2 shared Alison Figueroa AlmedaiD· 1 shared Anna C. HookeriD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Hanlee P. JiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Stomach Malignancies

Alison Figueroa Almeda, Susan M. Grimes, HoJoon Lee, Stephanie Greer, Gi Won Shin, Madeline McNamara, Anna C. Hooker, Maya M. Arce, Matthew A. Kubit, Marie C. Schauer, Paul Van Hummelen, Cindy S. Ma, Meredith A. Mills, Robert J. Huang, Joo Ha Hwang, , Hanlee P. Ji

The paper describes the development of a gastric cancer registry integrating clinical and genomic data to support translational research.

Cancer Epidemiology Biomarkers & Prevention · Jun 30, 2022Peer-reviewedGenetic & Genomic Medicine

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

Li C. Xia, Paul Van Hummelen, Matthew A. Kubit, HoJoon Lee, John Bell, Susan M. Grimes, Christina M. Wood-Bouwens, Stephanie Greer, Tyler Barker, Derrick S. Haslem, James M. Ford, Gail Fulde, Hanlee P. Ji, Lincoln D. Nadauld

The paper identifies TP53 genomic deletions as a poor prognosis marker in Stage III colorectal cancer using a new low-coverage whole-genome sequencing protocol.

Scientific Reports · Mar 19, 2020Peer-reviewedGenomics